基于MRI评估三阴性乳腺癌新辅助治疗疗效研究进展  

Progress in MRI based evaluation of neoadjuvant therapy for triple-negative breast cancer

作　　者：徐梦欢 任晓婧 钱华[2] XU Menghuan;REN Xiaojing;QIAN Hua(College of First Clinical Medical,Zhejiang Chinese Medical University,Hangzhou,Zhejiang 310053,China;Department of Medical Image,Zhejiang Hospital of Traditional Chinese Medicine,Hangzhou,Zhejiang 310000,China)

机构地区：[1]浙江中医药大学第一临床医学院,浙江杭州310053 [2]浙江省中医院医学影像科,浙江杭州310000

出　　处：《影像研究与医学应用》2022年第14期1-3,共3页Journal of Imaging Research and Medical Applications

摘　　要：三阴性乳腺癌具有侵袭性强、进展快、预后差等不良特点,且对内分泌治疗或分子靶向治疗不敏感。目前,新辅助治疗已成为三阴性乳腺癌的规范疗法,也是最常用的综合治疗方法。近年来,磁共振成像(magnetic resonance imaging,MRI)在评估新辅助治疗疗效方面具有一定的价值,是目前研究的热点。本文对MRI评估三阴性乳腺癌新辅助治疗疗效研究进展作详细地阐述。Triple-negative breast cancer is characterized by strong aggressiveness,rapid progression and poor prognosis,and is not sensitive to endocrine therapy or molecular targeted therapy.At present,neoadjuvant therapy has become the standard treatment for TNBC,and it is also the most commonly used comprehensive treatment method.In recent years,MRI has a certain value in evaluating the efficacy of neoadjuvant therapy and is a hotspot of current research.This paper reviews the progress of MRI in the evaluation of neoadjuvant therapy for triple negative breast cancer.

关 键 词：三阴性乳腺癌 新辅助治疗 磁共振成像 

分 类 号：R445[医药卫生—影像医学与核医学]